全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Takuya Koie , Ippei Takahashi ...
来源:[J].BMC Urology(IF 1.694), 2017, Vol.17 (1)Springer
摘要:The aim of the present study is to investigate the clinical relevance of aortic calcification in urolithiasis patients.
作者:Takuya Koie , Shogo Hosogoe ...
来源:[J].BMC Urology(IF 1.694), 2017, Vol.17 (1)Springer
摘要:Urinary tract obstruction and postoperative hydronephrosis are risk factor for renal function deterioration after orthotopic ileal neobladder construction. However, reports of relationship between transient hydronephrosis and renal function are limited.
作者:Takuya Koie , Yuriko Terayama ...
来源:[J].BMC Urology(IF 1.694), 2017, Vol.17 (1)Springer
摘要:Radical nephrectomy for renal cell carcinoma (RCC) is a risk factor for the development of chronic kidney disease (CKD), and the possibility of postoperative deterioration of renal function must be considered before surgery. We investigated the contribution of the aortic calcific...
作者:Takuya Koie , Chikara Ohyama ...
来源:[J].International Journal of Clinical Oncology(IF 1.727), 2017, Vol.22 (6), pp.1087-1093Springer
摘要:The optimal treatment for high-risk prostate cancer (PCa) remains to be established. We previously reported favorable, biochemical recurrence-free survival in high-risk PCa patients treated with a neoadjuvant gonadotropin-releasing hormone agonist or antagonist and estramustine p...
作者:... Yasuhiro Hashimoto , Takuya Koie , Chikara Ohyama
来源:[J].International Journal of Clinical Oncology(IF 1.727), 2017, Vol.22 (2), pp.366-372Springer
摘要:Although quality of life (QOL) is one of the most important considerations in patients treated with anticancer therapies, desirable regimens for neoadjuvant chemotherapy including QOL in locally advanced urothelial carcinoma remain unclear. The present study evaluated the influen...
作者:Takuya Koie , Sadafumi Kawamura ...
来源:[J].Medical Oncology(IF 2.147), 2017, Vol.34 (12)Springer
摘要:The aim of the present study was to assess the cost-effectiveness of extended pelvic lymph node dissection (ePLND) compared to neoadjuvant chemohormonal therapy using gonadotropin-releasing hormone agonist/antagonist and estramustine. We retrospectively analyzed data within Michi...
作者:Takuya Koie , Toshiaki Kawaguchi
来源:[J].Medical Oncology(IF 2.147), 2017, Vol.34 (6)Springer
摘要:Programmed cell death ligand-1 (PD-L1) is a key target molecule of immunotherapy that is frequently overexpressed in bladder cancer. In the present study, we examined whether PD-L1 expression is associated with clinical outcomes in bladder cancer patients. We enrolled 102 bl...
作者:Takuya Koie , Chikara Ohyama ...
来源:[J].International Urology and Nephrology(IF 1.325), 2017, Vol.49 (5), pp.811-816Springer
摘要:The optimal treatment for high-risk prostate cancer (Pca) remains to be established. We previously reported favorable biochemical recurrence-free survival (BRFS) for high-risk Pca patients treated with neoadjuvant therapy comprising a luteinizing hormone-releasing hormone agonist...
作者:Takuya Koie , Hiroyuki Ito ...
来源:[J].Medical Oncology(IF 2.147), 2017, Vol.34 (5)Springer
摘要:The prognostic benefit of oncological follow-up to detect asymptomatic recurrence after radical cystectomy (RC) remains unclear. We aimed to assess whether routine follow-up to detect asymptomatic recurrence after RC improves patient survival. We retrospectively analyzed 581...
作者:Takuya Koie , Chikara Ohyama ...
来源:[J].BMC Urology(IF 1.694), 2015, Vol.15 (1)Springer
摘要:Abstract(#br) Background(#br)Clinical benefit of axitinib as a first line agent to treat patients with metastatic renal cell carcinoma (mRCC), or locally advanced renal cell carcinoma (RCC) have not been clearly demonstrated. The aim of this study was to evaluate the efficac...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×